Revenue: Total revenue, consisting primarily of revenue from collaboration agreements, was $15 million for the first quarter ...

In his new role as CFO at BioNTech, Ramón Zapata will ensure the Company's financial direction continues to align with BioNTech's strategy to become a multi-product company in the oncology field. In ...

Mainz, Germany, May 5, 2025(Nasdaq: BNTX, "BioNTech" or "the Company") announced today that the Supervisory Board has appointed Ramón Zapata-Gomez to the Management Board as Chief Financial Officer (" ...

Recursion said it earned its latest milestone payout by identifying differentiated, oral small molecule leads against a target the company described as a high interest immune cell target in immunology ...

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

Welcome to the Adaptive Biotechnologies first-quarter 2025 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the ...

ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced ...

I am excited to partner with management and the Board of Directors to help shape the clinical development and commercial strategy for their growing portfolio ... at Genentech, Inc., a member ...

Jobevne, which is a recombinant humanized monoclonal antibody used to treat several different types of cancer, is a biosimilar to Genentech ... biosimilar oncology portfolio in the United ...

Biogen’s lack of insider buying and reduced R&D spending raise concerns, but its future growth prospects remain. Find out why ...

Learn more about whether Alvotech or Recursion Pharmaceuticals, Inc. is a better investment based on AAII's A+ Investor ...

INDIANAPOLIS — Roche, a Swiss biotechnology company whose U.S. headquarters is in Indianapolis, has announced its intention ...